Novel anti-microbial peptide SR-0379 accelerates wound healing via the PI3 kinase/Akt/mTOR pathway.

PubWeight™: 0.78‹?›

🔗 View Article (PMC 3968008)

Published in PLoS One on March 27, 2014

Authors

Hideki Tomioka1, Hironori Nakagami2, Akiko Tenma3, Yoshimi Saito3, Toshihiro Kaga3, Toshihide Kanamori3, Nao Tamura3, Kazunori Tomono4, Yasufumi Kaneda5, Ryuichi Morishita6

Author Affiliations

1: Department of Clinical Gene Therapy, Osaka University Graduate School of Medicine, 2-2 Yamada-oka, Suita, Osaka, Japan; AnGesMG, Inc., 7-7-15 Saito Bio-Incubator, Ibaraki, Osaka, Japan.
2: Division of Vascular Medicine and Epigenetics, Osaka University United Graduate School of Child Development, 2-1 Yamada-oka, Suita, Osaka, Japan.
3: AnGesMG, Inc., 7-7-15 Saito Bio-Incubator, Ibaraki, Osaka, Japan.
4: Division of Infection Control and Prevention, Graduate School of Medicine, 2-2 Yamada-oka, Suita, Osaka, Japan.
5: Division of Gene Therapy Science, Osaka University Graduate School of Medicine, School of Child Development, 2-1 Yamada-oka, Suita, Osaka, Japan.
6: Department of Clinical Gene Therapy, Osaka University Graduate School of Medicine, 2-2 Yamada-oka, Suita, Osaka, Japan.

Articles cited by this

Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol (2006) 10.15

Defensins. Natural peptide antibiotics of human neutrophils. J Clin Invest (1985) 8.63

Peptide antibiotics and their role in innate immunity. Annu Rev Immunol (1995) 6.81

Peptide antibiotics. Lancet (1997) 6.76

APD2: the updated antimicrobial peptide database and its application in peptide design. Nucleic Acids Res (2008) 4.23

Fibroblast-collagen-matrix contraction: growth-factor signalling and mechanical loading. Trends Cell Biol (2000) 2.49

Bacteria and wound healing. Curr Opin Infect Dis (2004) 2.43

In vitro antibacterial properties of pexiganan, an analog of magainin. Antimicrob Agents Chemother (1999) 2.10

Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study. Diabetes Care (1998) 2.09

A review of antimicrobial peptides and their therapeutic potential as anti-infective drugs. Curr Eye Res (2005) 1.97

A comprehensive summary of LL-37, the factotum human cathelicidin peptide. Cell Immunol (2012) 1.79

Potential therapeutic applications of magainins and other antimicrobial agents of animal origin. Ciba Found Symp (1994) 1.58

Structure, membrane orientation, mechanism, and function of pexiganan--a highly potent antimicrobial peptide designed from magainin. Biochim Biophys Acta (2008) 1.31

Accelerated wound healing by mTOR activation in genetically defined mouse models. PLoS One (2010) 1.25

The fibroblast-populated collagen matrix as a model of wound healing: a review of the evidence. Wound Repair Regen (2004) 1.23

Peripheral blood fibrocytes: enhancement of wound healing by cell proliferation, re-epithelialization, contraction, and angiogenesis. Ann Surg (2011) 1.17

Design and characterization of novel hybrid antimicrobial peptides based on cecropin A, LL-37 and magainin II. Peptides (2012) 0.93

Comparison of the effects of moist and dry conditions on dermal repair. J Invest Dermatol (1988) 0.92

Improved proteolytic stability of chicken cathelicidin-2 derived peptides by D-amino acid substitutions and cyclization. Peptides (2011) 0.91

The quality of pediatric burn scars is improved by early administration of basic fibroblast growth factor. J Burn Care Res (2006) 0.87

Development of a novel antimicrobial peptide, AG-30, with angiogenic properties. J Cell Mol Med (2008) 0.84

A randomized controlled trial to evaluate an antimicrobial dressing with silver alginate powder for the management of chronic wounds exhibiting signs of critical colonization. Adv Skin Wound Care (2012) 0.79

Enhanced angiogenesis and granulation tissue formation by basic fibroblast growth factor in healing-impaired animals. Arzneimittelforschung (1996) 0.78

Modification of a novel angiogenic peptide, AG30, for the development of novel therapeutic agents. J Cell Mol Med (2012) 0.78

Investigating the effects of L- to D-amino acid substitution and deamidation on the activity and membrane interactions of antimicrobial peptide anoplin. Biochim Biophys Acta (2010) 0.77